Commodity Chemicals

Braskem SA

Braskem SA released FY2026 Q1 earnings on May 14 After-Market EST: Actual Revenue USD 2.952 B (Forecast USD 3.624 B), Actual EPS USD 0.6916 (Forecast USD 0.6804)

Braskem Faces Q1 2026 Financial Distress, Auditor Warns of Going Concern Risks, Analysts Downgrade Rating

Braskem SA to Release FY2026 Q1 Earnings on May 11, 2026 (EST), Forecast Revenue USD 3.671 B

Braskem SA released FY2025 Q4 earnings on March 27 (EST), actual revenue USD 2.94 B (forecast USD 2.969 B), actual EPS USD 0 (forecast USD -0.9935)

Braskem SA released FY2025 earnings on March 27 (EST), actual revenue USD 12.87 B (forecast USD 13.1 B), actual EPS USD -4.5115 (forecast USD -0.8941)

Braskem SA to release FY2025 earnings report on March 25, 2026, during market hours EST, with forecasted revenue of USD 13.74 B and EPS of USD -0.7994

Fitch Downgrades Braskem's Global Corporate Credit Rating to CC

Braskem SA Signs Long-term Supply Contract with Petrobras

Petrobras Signs Long-Term Supply Contracts for Naphtha and Propylene with Braskem

Braspetro Holds Special Shareholders Meeting to Approve Board Changes and Amend Charter

Braskem SA released FY2025 Q3 earnings on November 11 (EST), actual revenue USD 3.252 B (forecast USD 3.258 B), actual EPS USD -0.0122 (forecast USD -0.6113)

Braskem SA released FY2025 9 Months Earnings on November 11 After-Market EST, with actual revenue of USD 9.886 B and EPS of USD 0.1695

Braskem SA Reports Q3 EBITDA Growth of 91%

Braskem SA to release FY2025 Q3 earnings on November 10, 2025 (EST), forecast revenue USD 3.235 B, EPS USD -0.6113

Braskem to showcase carbon reduction strategies at COP30

Braskem's stock price rises despite analyst downgrade

Brazilian Government Maintains Resin Import Tax at 20% Until October 2026

Braskem S.A. faces investigation for potential securities fraud

Braskem showcases bio-based product innovations at K 2025

Braskem SA's Credit Rating Downgraded to BB- by S&P Global Ratings

Liminatus Pharma

Agape ATP

Sunshine Biopharma

NewGenIvf

Co-Diagnostics

AIAI

Tradr 2X Long QBTS Daily ETF

Tradr 2X Long RGTI Daily ETF

Wheeler Real Estate

Quantum Cyber NV

Braskem reported a consolidated recurring EBITDA of $192 million for Q1 2026, a 76% increase from Q4 2025, driven by higher utilization rates. However, the Mexico segment faced challenges with a negative recurring EBITDA of $50 million. The company is focusing on restructuring its capital and implementing a Resilience Plan. Braskem's cash position was $1.1 billion, and it anticipates improved petrochemical spreads, contingent on geopolitical developments in the Middle East.

benzinga_article

Braskem Q1 2026 Earnings Call: Complete Transcript

Braskem S.A. reported significant financial distress in its Q1 2026 review, with current liabilities surpassing total assets by R$2.7 billion at the parent level and R$10.7 billion consolidated. The auditor, KPMG, noted a material uncertainty regarding the company's ability to continue as a going concern, despite no modifications to the review conclusion. Analysts currently rate BAK stock as a Sell with a $3.20 price target, citing weak financial performance and high debt, while Spark's AI Analyst gives it a Neutral rating due to risks and liquidity concerns.

Tip Ranks

Braskem’s Q1 2026 Review Flags Material Doubt Over Going-Concern Status

Braskem shares are trading higher. Reports suggest that its Braskem Idesa JV is closing in on a bankruptcy loan agreement.

Braskem SA's stock price target has been raised to $4.56, indicating a potential downside of 5% based on the May 12 closing price. The average target, estimated by 9 analysts, ranges from $1.5 to $6.13 per share. The consensus rating remains a "Hold" with 3 Buys, 4 Holds, and 2 Sells among the analysts.

TradingView

Factset Research

Braskem SA Stock 12‑Month Price Target Raised to $4.56, Implies 5% Downside

Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade | BAK Stock News

StockTitan

Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade | BAK Stock News

BRZU

Braskem SA shareholders approved the company's financial statements for 2025 and confirmed new board leadership during the Ordinary General Meeting on April 29, 2026. Over 80% of share capital supported the approval, indicating strong investor confidence. Magda Maria de Regina Chambriard was confirmed as chair, and Héctor Núñez as vice-chair. Despite this, analysts rate BAK stock as a Sell due to weak financial performance and high leverage, with a price target of $1.50. Braskem operates in the petrochemical sector, focusing on producing raw materials for various industries.

Direxion Daily MSCI Brazil Bull 2X

Pro Ultrshrt MSCI Brazil CPro

Pro Ultr MSCI Brazil CPro

Braskem Shareholders Approve 2025 Accounts and Confirm New Board Leadership

PBR.A

Brazilian petrochemical firm Braskem has elected Magda Chambriard, CEO of state-run oil company Petrobras, as its new chairperson during a recent board election. This decision was reported by local newspaper Folha de S. Paulo, although neither Braskem nor Petrobras provided immediate comments on the matter.

Fidelity

Petroleo Brasileiro SA

Petroleo Brasileiro

Brazil's Braskem elects Petrobras CEO as new chair, reports Folha

Braskem SA has scheduled a digital extraordinary general meeting for May 28, 2026, to discuss governance changes following a shareholding transaction involving a judicial sale of a significant stake to an investment fund. The meeting will allow voting from all classes of shares and aims to align the company's bylaws with a new shareholders' agreement. Key agenda items include bylaw amendments, board elections, and fiscal council replacements. Analysts currently rate Braskem's stock as a Sell, citing weak financial performance and high leverage.

Braskem Sets May 28 Digital EGM to Overhaul Governance Amid New Control Deal

Braskem SA(BAK.US)

Braskem Q1 2026 Earnings Call: Complete Transcript

Braskem’s Q1 2026 Review Flags Material Doubt Over Going-Concern Status

Braskem shares are trading higher. Reports suggest that its Braskem Idesa JV is closing in on a bankruptcy loan agreement.

Braskem SA Stock 12‑Month Price Target Raised to $4.56, Implies 5% Downside

Braskem Celebrates Naming of Beautiful Future and Blooming Future, Next‑Generation Tankers for Cleaner Global Trade | BAK Stock News

Braskem Shareholders Approve 2025 Accounts and Confirm New Board Leadership

Brazil's Braskem elects Petrobras CEO as new chair, reports Folha

Braskem Sets May 28 Digital EGM to Overhaul Governance Amid New Control Deal